Company intelligence / Profile preview
Key2Brain
Solna, Swedenkey2brain.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Key2Brain’s platform has demonstrated efficient brain uptake and broad distribution of various therapeutic modalities in preclinical models. The company is advancing several internal and partnered programs, but no clinical results have been published yet.
- Therapeutic areas
- Neurology
- Modalities
- Single domain antibody (VHH)PeptidesProteinsEnzymesMonoclonal antibodyOligonucleotide
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Academic collaborations at Karolinska Institute and other institutionsIndustry partnerships for co-development of therapies
Beyond the preview
Go deeper on Key2Brain.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Key2Brain.